Application 006035
- Type
- NDA
- Sponsor
- EDISON THERAPS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 003 | METHERGINE | METHYLERGONOVINE MALEATE | TABLET;ORAL | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 004 | METHERGINE | METHYLERGONOVINE MALEATE | INJECTABLE;INJECTION | 0.2MG/ML | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N006035-003 | METHERGINE | METHYLERGONOVINE MALEATE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | ||
| N006035-004 | METHERGINE | METHYLERGONOVINE MALEATE | 0.2MG/ML | INJECTABLE / INJECTION | RLD, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N006035-003 | METHERGINE | 0.2MG | TABLET / ORAL | RLD, Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N006035-003 | METHERGINE | 0.2MG | TABLET / ORAL | RLD, Approved before 1982 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD, Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N006035-003 | METHERGINE | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD, Approved before 1982 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N006035-004 | METHERGINE | 0.2MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N006035-004 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N006035-004 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N006035-004 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N006035-004 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N006035-004 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N006035-004 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N006035-004 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N006035-004 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N006035-004 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N006035-004 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N006035-004 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N006035-004 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N006035-004 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N006035-004 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N006035-004 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N006035-004 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N006035-004 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N006035-004 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N006035-004 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N006035-004 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N006035-004 | AP | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N006035-004 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N006035-004 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N006035-004 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N006035-004 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N006035-004 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N006035-004 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N006035-004 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N006035-004 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N006035-004 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N006035-004 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N006035-004 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N006035-004 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N006035-004 | AP | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylergonovine Maleate | METHYLERGONOVINE MALEATE | Teva Pharmaceuticals USA, Inc. | d8e4b8ed-3289-4611-8a61-2392a4bf6072 | 2026-05-26 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| Methylergonovine Maleate | METHYLERGONOVINE MALEATE | Major Pharmaceuticals | c7f19e89-8b52-4033-9914-f3b41fe0790d | 2026-04-30 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| METHYLERGONOVINE MALEATE | METHYLERGONOVINE MALEATE | HF Acquisition Co. LLC. DBA HealthFirst | 4ddcdfff-1468-bff0-e063-6294a90a5480 | 2026-03-25 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| Methylergonovine Maleate | METHYLERGONOVINE MALEATE | American Regent, Inc. | a9a3079e-b62b-4858-920e-d8f5cb38481e | 2026-03-04 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| METHYLERGONOVINE MALEATE | METHYLERGONOVINE MALEATE | Pharmacist Pharmaceutical, LLC | 17ee0c79-ac98-4400-ae77-985978fca07e | 2025-12-12 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| Methylergonovine Maleate | METHYLERGONOVINE MALEATE | American Health Packaging | 98ad5af1-bde6-4137-a599-b6354d664da4 | 2025-11-13 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| METHYLERGONOVINE MALEATE | METHYLERGONOVINE MALEATE | Breckenridge Pharmaceutical, Inc. | 8bccff44-2a39-400a-b8a4-2eb5249fdbc8 | 2025-07-09 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| Methylergonovine Maleate | METHYLERGONOVINE MALEATE | Rising Pharma Holdings, Inc. | 465b292b-0e0e-4a55-894e-90234efe2a12 | 2025-06-19 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| Methylergonovine Maleate | METHYLERGONOVINE MALEATE | Granules Pharmaceuticals Inc. | b49b1e4c-de20-446d-b80a-75c7f0d41ddf | 2025-06-17 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| METHYLERGONOVINE MALEATE | METHYLERGONOVINE MALEATE | Bryant Ranch Prepack | 885b98d9-ba2c-48fb-b3b8-940e5f5e93d6 | 2024-05-30 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| METHYLERGONOVINE MALEATE | METHYLERGONOVINE MALEATE | Bryant Ranch Prepack | 8a6fe76c-d709-419e-885e-fa2ce07df27b | 2024-05-29 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| METHYLERGONOVINE MALEATE | METHYLERGONOVINE MALEATE | HF Acquisition Co LLC, DBA HealthFirst | c4c48277-eb9e-6150-e053-2a95a90ab21d | 2024-05-17 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| Methylergonovine Maleate | METHYLERGONOVINE MALEATE | Volley Pharmaceuticals, LLC | 0a318b77-d280-4571-992f-82e2e0a57c9b | 2024-03-21 | Warnings, Adverse reactions | METHYLERGONOVINE MALEATE |
| Methergine | METHYLERGONOVINE MALEATE | Lupin Pharmaceuticals,Inc. | 3f04ca06-fe52-46d6-96cd-2e77ef6fa36f | 2024-03-20 | Warnings, Adverse reactions | Methergine METHYLERGONOVINE MALEATE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 12634-179 | METHERGINE | METHYLERGONOVINE MALEATE | Apotheca, Inc. | NDA | Current |
| 63629-3791 | Methergine | methylergonovine maleate | Bryant Ranch Prepack | NDA | Current |
| 66336-402 | Methergine | methylergonovine maleate | Dispensing Solutions, Inc. | NDA | Current |